Materials and
Methods: In the years 2004-2008, 4619 African American and Caucasian women gave birth to a single, live, and full-term infant, completed Arkansas Pregnancy Risk Assessment Monitoring System questions about gestational weight gain and prepregnancy weight status, and gained within or in excess of the guidelines.
https://www.selleckchem.com/products/Neratinib(HKI-272).html Logistic regression was used to identify sociodemographic and health variables associated with the odds of exceeding the 2009 IOM guidelines overall and by race.
Results: Regardless of race, overweight (odds ratio [OR] = 3.21; 95% confidence interval [CI]: 2.64-3.91) and obese (OR = 4.37; 95% CI: 3.50-5.46) women had significantly higher odds of gaining excessively, as compared with normal weight women. In the multivariate model, women who were overweight or obese prepregnancy and who were married had higher odds of exceeding the IOM guidelines, while lower odds of exceeding the guidelines were seen among
African American women, those who had Medicaid at any point in their pregnancy, who were multiparous, and those of Hispanic ethnicity.
Discussion: These findings can inform efforts to promote appropriate gestational weight gain among those at highest risk (i.e., overweight/obese women) and facilitate targeting to produce ASP2215 greatest improvement in the health of mothers and children.”
“Objective: To determine the effect of hyperglycemia, which is associated with poor outcome of various selleck products diseases, on the outcome of hematopoietic stem cell transplantation (HSCT).
Methods: We examined
the influence of blood glucose concentration (BGC) on the outcome of autologous HSCT. Patients had at least one BGC determination every morning during their hospitalization. The relationships of BGC with time to engraftment and length of hospital stay (LOHS) after transplantation were analyzed.
Results: The correlation of LOHS after transplantation was found only with posttransplant averaged BGC (P = .0004) in patients without diabetes (N = 240) but not with pretransplant. averaged BGC or BGC on the morning of transplantation. The correlation remained significant after adjustment for sex, age, and body mass index (P = .0002) and for use of glucocorticoids and total parenteral nutrition (P = .04). No correlation was observed, however, between BGC and timing of engraftment. We further analyzed the entire data set of subjects (N = 335) on the basis of posttransplant morning BGC and divided these patients into 2 groups: those with BGC <150 mg/dL and those with BGC >= 150 mg/dL.